Bio-Works

Bio-Works

Uppsala, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $55.5M

Overview

Bio-Works is a specialized provider of chromatography purification solutions, serving the global biopharmaceutical industry from its base in Uppsala, Sweden. The company leverages deep expertise in agarose resin technology to produce its flagship WorkBeads™ resins and GoBio™ pre-packed columns, which are critical for downstream processing in drug manufacturing. With a certified ISO 9001 quality system and a strong customer support focus, Bio-Works has established itself as a trusted partner, with its products cited in numerous industry publications and used in the purification of over 15 commercial drugs. The company operates as a private, revenue-generating business-to-business supplier within the biologics manufacturing value chain.

AntibodiesBiologics

Technology Platform

Proprietary agarose-based chromatography resin platform (WorkBeads™) featuring beads with tight bead- and pore-size distribution for high purity, binding capacity, and flow rates in biomolecule purification.

Funding History

3
Total raised:$55.5M
Series B$30M
Series A$15M
IPO$10.5M

Opportunities

The expanding global biopharmaceutical market, particularly for complex biologics like antibodies, vaccines, and cell/gene therapies, drives continuous demand for high-performance purification tools.
Growing industry emphasis on sustainable manufacturing aligns with Bio-Works' operational commitments, offering a potential competitive advantage.
The trend toward flexible and decentralized manufacturing increases the need for reliable, ready-to-use pre-packed columns like the GoBio™ line.

Risk Factors

Intense competition from large, established multinational corporations dominating the chromatography consumables market.
Dependence on the biopharma industry's health and R&D spending cycles, with potential customer concentration risk.
Vulnerability to supply chain disruptions for critical raw materials like agarose and potential long-term technological disruption from alternative purification methods.

Competitive Landscape

Bio-Works competes in the chromatography resin market against large, diversified life science tools giants such as Cytiva (Danaher), Thermo Fisher Scientific, and Merck KGaA. Its competitive strategy is based on differentiation through superior product performance (tight bead-size distribution), deep technical expertise in agarose chemistry, and a strong focus on customer support and partnership, rather than competing solely on scale or price.